We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward. Here are the measures that the...
Select a resource from the topic displayed
Our Mission Statement
HISTOLOGIX CELEBRATES COMMITMENT TO REAL LIVING WAGE
HistologiX will hold a presence at the DPC this year. We would love to talk you through our slide scanning and archiving services via the Hamamatsu and Zeiss Digital Slide Scanners. We also use HALO™ Image Analysis on behalf of our clients and provide scientific interpretation to aid your study decisions.
If you are planning to attend this popular event, please visit us at Booth #15 to learn about our advances in all of the above therapeutic areas.
Visit stand #2 at Next Gen Immuno-Oncology Congress, on. 19-20th September 2019 to meet our team and discuss how we might be able to drive your immuno-oncology programmes
HistologiX have entered into partnership with the Medicines Discovery Catapult to enable science and boost growth within the UK and international R&D Life SCiences Industry. Please CLICK HERE to read more
As part of our continued development of Histologix services we are pleased to announce that the reading of all future GLP-compliant therapeutic antibody cross-reactivity studies will be undertaken by a British (FRCPath), American (DiplACVP) board-certified veterinary...